Caitlin John’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-1,100
Closed -$195K – 130
2024
Q4
$195K Buy
+1,100
New +$202K 0.13% 132

Other funds holding ABBV

Caitlin John's ABBV Position: Q3 2026 in Review

Caitlin John reduced its AbbVie (ABBV) stake by 0.67% in Q3 2026, selling an estimated $256 and leaving 148 shares worth $38.6K. The position accounts for 0.02% of the portfolio, ranked #412.

Caitlin John first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,285 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Caitlin John held 148 shares of AbbVie worth $38.6K as of Q3 2026.
  • Caitlin John sold 1 AbbVie share in Q3 2026, an estimated $256.
  • AbbVie made up 0.02% of Caitlin John's portfolio in Q3 2026, its #412 holding.
  • Caitlin John first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,285 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Caitlin John's 13F filing for Q3 2026, filed 16 Nov 2026.